ARGENX SE (ARGX.BR) Stock Fundamental Analysis
Europe - EBR:ARGX - NL0010832176 - Common Stock
705.6 EUR
+3.2 (+0.46%)
We assign a fundamental rating of 6 out of 10 to ARGX. ARGX was compared to 73 industry peers in the Biotechnology industry. ARGX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ARGX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make ARGX a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
ARGX had positive earnings in the past year.
ARGX had a positive operating cash flow in the past year.
ARGX had negative earnings in 4 of the past 5 years.
In the past 5 years ARGX always reported negative operating cash flow.
1.2 Ratios
The Return On Assets of ARGX (17.84%) is better than 89.04% of its industry peers.
ARGX has a better Return On Equity (21.00%) than 86.30% of its industry peers.
ARGX's Return On Invested Capital of 5.71% is amongst the best of the industry. ARGX outperforms 83.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.84% | ||
| ROE | 21% | ||
| ROIC | 5.71% |
ROA(3y)-5.23%
ROA(5y)-11.34%
ROE(3y)-5.76%
ROE(5y)-13.95%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 41.97%, ARGX belongs to the best of the industry, outperforming 93.15% of the companies in the same industry.
With an excellent Operating Margin value of 15.30%, ARGX belongs to the best of the industry, outperforming 83.56% of the companies in the same industry.
The Gross Margin of ARGX (89.40%) is better than 83.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.3% | ||
| PM (TTM) | 41.97% | ||
| GM | 89.4% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ARGX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ARGX has been increased compared to 1 year ago.
The number of shares outstanding for ARGX has been increased compared to 5 years ago.
Compared to 1 year ago, ARGX has a worse debt to assets ratio.
2.2 Solvency
ARGX has an Altman-Z score of 29.18. This indicates that ARGX is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 29.18, ARGX belongs to the best of the industry, outperforming 98.63% of the companies in the same industry.
The Debt to FCF ratio of ARGX is 0.14, which is an excellent value as it means it would take ARGX, only 0.14 years of fcf income to pay off all of its debts.
ARGX has a Debt to FCF ratio of 0.14. This is amongst the best in the industry. ARGX outperforms 95.89% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that ARGX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.01, ARGX belongs to the top of the industry, outperforming 84.93% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.14 | ||
| Altman-Z | 29.18 |
ROIC/WACC0.76
WACC7.52%
2.3 Liquidity
A Current Ratio of 5.60 indicates that ARGX has no problem at all paying its short term obligations.
ARGX has a better Current ratio (5.60) than 83.56% of its industry peers.
A Quick Ratio of 5.27 indicates that ARGX has no problem at all paying its short term obligations.
ARGX has a Quick ratio of 5.27. This is amongst the best in the industry. ARGX outperforms 84.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.6 | ||
| Quick Ratio | 5.27 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 1512.50% over the past year.
The Revenue has grown by 78.60% in the past year. This is a very strong growth!
The Revenue has been growing by 94.61% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1512.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%272.66%
Revenue 1Y (TTM)78.6%
Revenue growth 3Y63.92%
Revenue growth 5Y94.61%
Sales Q2Q%95.51%
3.2 Future
ARGX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 103.72% yearly.
Based on estimates for the next years, ARGX will show a very strong growth in Revenue. The Revenue will grow by 32.89% on average per year.
EPS Next Y805.38%
EPS Next 2Y278.4%
EPS Next 3Y166.67%
EPS Next 5Y103.72%
Revenue Next Year85.31%
Revenue Next 2Y56.35%
Revenue Next 3Y43.79%
Revenue Next 5Y32.89%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 65.58, which means the current valuation is very expensive for ARGX.
Based on the Price/Earnings ratio, ARGX is valued a bit cheaper than 78.08% of the companies in the same industry.
ARGX is valuated expensively when we compare the Price/Earnings ratio to 26.10, which is the current average of the S&P500 Index.
ARGX is valuated quite expensively with a Price/Forward Earnings ratio of 32.90.
Based on the Price/Forward Earnings ratio, ARGX is valued a bit cheaper than the industry average as 78.08% of the companies are valued more expensively.
ARGX is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.52, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 65.58 | ||
| Fwd PE | 32.9 |
4.2 Price Multiples
72.60% of the companies in the same industry are more expensive than ARGX, based on the Enterprise Value to EBITDA ratio.
79.45% of the companies in the same industry are more expensive than ARGX, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 162.53 | ||
| EV/EBITDA | 90.47 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ARGX's earnings are expected to grow with 166.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y278.4%
EPS Next 3Y166.67%
5. Dividend
5.1 Amount
ARGX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EBR:ARGX (10/31/2025, 7:00:00 PM)
705.6
+3.2 (+0.46%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners41.51%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap43.44B
Revenue(TTM)2.19B
Net Income(TTM)1.28B
Analysts84.8
Price Target735.32 (4.21%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)7.11%
Max EPS beat(2)23.2%
EPS beat(4)3
Avg EPS beat(4)3962.36%
Min EPS beat(4)-38.07%
Max EPS beat(4)15857.2%
EPS beat(8)5
Avg EPS beat(8)1996.71%
EPS beat(12)8
Avg EPS beat(12)1343.38%
EPS beat(16)12
Avg EPS beat(16)1012.62%
Revenue beat(2)1
Avg Revenue beat(2)3.68%
Min Revenue beat(2)-0.81%
Max Revenue beat(2)8.17%
Revenue beat(4)3
Avg Revenue beat(4)5.02%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)8.17%
Revenue beat(8)6
Avg Revenue beat(8)5.96%
Revenue beat(12)10
Avg Revenue beat(12)14%
Revenue beat(16)13
Avg Revenue beat(16)17.53%
PT rev (1m)1.6%
PT rev (3m)7.26%
EPS NQ rev (1m)-1.35%
EPS NQ rev (3m)27.2%
EPS NY rev (1m)0%
EPS NY rev (3m)33.8%
Revenue NQ rev (1m)0.19%
Revenue NQ rev (3m)11.71%
Revenue NY rev (1m)0.96%
Revenue NY rev (3m)12.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 65.58 | ||
| Fwd PE | 32.9 | ||
| P/S | 16.45 | ||
| P/FCF | 162.53 | ||
| P/OCF | 124.28 | ||
| P/B | 8.23 | ||
| P/tB | 8.54 | ||
| EV/EBITDA | 90.47 |
EPS(TTM)10.76
EY1.52%
EPS(NY)21.45
Fwd EY3.04%
FCF(TTM)4.34
FCFY0.62%
OCF(TTM)5.68
OCFY0.8%
SpS42.9
BVpS85.72
TBVpS82.64
PEG (NY)0.08
PEG (5Y)N/A
Graham Number144.06
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.84% | ||
| ROE | 21% | ||
| ROCE | 7.61% | ||
| ROIC | 5.71% | ||
| ROICexc | 15.87% | ||
| ROICexgc | 17.62% | ||
| OM | 15.3% | ||
| PM (TTM) | 41.97% | ||
| GM | 89.4% | ||
| FCFM | 10.12% |
ROA(3y)-5.23%
ROA(5y)-11.34%
ROE(3y)-5.76%
ROE(5y)-13.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.14 | ||
| Debt/EBITDA | 0.07 | ||
| Cap/Depr | 428.74% | ||
| Cap/Sales | 3.12% | ||
| Interest Coverage | 519.07 | ||
| Cash Conversion | 82.6% | ||
| Profit Quality | 24.11% | ||
| Current Ratio | 5.6 | ||
| Quick Ratio | 5.27 | ||
| Altman-Z | 29.18 |
F-Score5
WACC7.52%
ROIC/WACC0.76
Cap/Depr(3y)176.19%
Cap/Depr(5y)545.91%
Cap/Sales(3y)10.66%
Cap/Sales(5y)13.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1512.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%272.66%
EPS Next Y805.38%
EPS Next 2Y278.4%
EPS Next 3Y166.67%
EPS Next 5Y103.72%
Revenue 1Y (TTM)78.6%
Revenue growth 3Y63.92%
Revenue growth 5Y94.61%
Sales Q2Q%95.51%
Revenue Next Year85.31%
Revenue Next 2Y56.35%
Revenue Next 3Y43.79%
Revenue Next 5Y32.89%
EBIT growth 1Y207%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1305.72%
EBIT Next 3Y205.97%
EBIT Next 5Y117.35%
FCF growth 1Y140.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y161.79%
OCF growth 3YN/A
OCF growth 5YN/A
ARGENX SE / ARGX.BR FAQ
What is the fundamental rating for ARGX stock?
ChartMill assigns a fundamental rating of 6 / 10 to ARGX.BR.
What is the valuation status of ARGENX SE (ARGX.BR) stock?
ChartMill assigns a valuation rating of 5 / 10 to ARGENX SE (ARGX.BR). This can be considered as Fairly Valued.
Can you provide the profitability details for ARGENX SE?
ARGENX SE (ARGX.BR) has a profitability rating of 5 / 10.
Can you provide the expected EPS growth for ARGX stock?
The Earnings per Share (EPS) of ARGENX SE (ARGX.BR) is expected to grow by 805.38% in the next year.